Artificial Intelligence in Drug Discovery Market to hit USD 15.50 billion by 2032 at CAGR of 29.89%
The Artificial Intelligence (AI) in Drug Discovery Market is experiencing remarkable growth, driven by the need for more efficient, faster, and cost-effective drug development processes. Traditional drug discovery is often slow, with an average time of 10-15 years and costs of up to USD 2.6 billion to bring a drug to market. AI technologies, particularly machine learning, deep learning, and natural language processing, can significantly reduce these timelines and costs by streamlining the discovery process and providing valuable insights from complex datasets.